Drug
Radiprodil
Radiprodil is a pharmaceutical drug with 5 clinical trials. Currently 4 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
4(80%)
Terminated
1(20%)
Phase Distribution
Ph phase_1
3
60%
Ph phase_3
1
20%
Ph phase_2
1
20%
Phase Distribution
3
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
4
trials recruiting
Total Trials
5
all time
Status Distribution
Active(4)
Terminated(1)
Detailed Status
Active, not recruiting2
Recruiting2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
4
Success Rate
0.0%
Most Advanced
Phase 3
Trials by Phase
Phase 13 (60.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
Trials by Status
active_not_recruiting240%
terminated120%
recruiting240%
Recent Activity
4 active trials
Showing 5 of 5
recruitingphase_1
Phase 1 Study of Radiprodil in Participants With Hepatic Impairment
NCT07457229
active_not_recruitingphase_1
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
NCT06392009
recruitingphase_3
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
NCT07224581
active_not_recruitingphase_1
Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder
NCT05818943
terminatedphase_2
A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS)
NCT02829827
Clinical Trials (5)
Showing 5 of 5 trials
NCT07457229Phase 1
Phase 1 Study of Radiprodil in Participants With Hepatic Impairment
NCT06392009Phase 1
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
NCT07224581Phase 3
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
NCT05818943Phase 1
Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder
NCT02829827Phase 2
A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS)
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5